New GSK chairman backs CEO Witty to stay at helm
LONDON, May 7 (Reuters) - GlaxoSmithKline's new chairman Philip Hampton expressed support for the company's current structure and its chief executive on Thursday while speaking to reporters after the drugmaker's annual meeting. Hampton said he hopes CEO Andrew Witty will continue to run GSK
Read more